Merz Continues Multi-Year ‘Beauty on Your Terms’ Campaign for XEOMIN
Merz adds another star to its galaxy of Xeomin partners
Merz Aesthetics Continues to Fuel Confidence by Expanding Belotero Balance® (+) Filler Treatment Areas
RALEIGH, N.C.--(BUSINESS WIRE)--Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced Teyana Taylor as the latest Xeomin® (incobotulinumtoxinA) brand partner. The U.S. partnership with Taylor is a continuation of the ground-breaking ‘Beauty on Your Terms’ campaign for Xeomin® and represents the first time the entertainer has partnered with an aesthetics brand. Xeomin® (pronounced phonetically: Zeo-min) is an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t.
The 33-year-old singer has signed up to become the new U.S. brand partner for Merz Aesthetics and its Botox-rivaling anti-wrinkle injection, Xeomin (incobotulinumtoxinA).
FRANKFURT, Germany--(BUSINESS WIRE)--Merz Aesthetics today confirmed its commitment as a global leader in medical aesthetics at the 2022 International Master Course on Aging Science (IMCAS) World Congress, with the presentation of data from its medical aesthetics portfolio and a clear focus on addressing the aesthetic needs of a diversifying society and a younger patient base. IMCAS, held from Friday, June 3 to Sunday, June 5, 2022, will take place in a hybrid format, enabling participants to attend the conference in person in Paris and/or virtually. Merz Aesthetics is a diamond sponsor of the global industry congress.